State · District of Columbia

Attorney General Clark Announces Multistate Settlement with Labcorp Over the American Medical Collection Agency Data Breach

Attorney General Tong Leads $2.3 Million Multistate Settlement with LabCorp Over the American Medical Collection Agency Data Breach

Full Story

Attorney General Ford Announces $2.3 Million Multistate Settlement with Labcorp Over Patient Data Breach

click here

Attorney General Brown Seeks Court Approval for $400 Million Multistate Settlement with Sandoz over Alleged Conspiracy to Inflate Prices and Limit Competition Published: 10/1/2026

Attorney General Jeff Jackson Reaches $2.2 Million Settlement with Labcorp Over 2019 Data Breach

Attorney General Phil Weiser announces $2.3M national settlement with Labcorp over data breach

Attorney General Mike Hilgers Announces Multistate Settlement with Labcorp over the American Medical Collection Agency Data Breach

Attorney General Bonta Challenges Rule Attempting to Block Federal Reimbursements for Providers of Gender-Affirming Care

Washington joins coalition challenging federal attack on gender-affirming healthcare for youth

Attorney General Phil Weiser sues Trump administration over latest attack on health care for transgender youth

Attorney General Dan Rayfield Challenges Trump Administration's Latest Attack on Healthcare

Attorney General Jay Jones Joins Coalition of States in Pushing Back on Federal Rule That Could Undermine Medicaid, Insurance Regulation, and Health Coverage

Attorney General Ford Opposes Federal Rule That Could Threaten Medicaid Funding and Health Coverage

Attorney General Brenna Bird Seeks Court Approval for $400 Million Settlement with Sandoz for Overcharging for Generic Drugs and Limiting Competition

Attorney General Tong Seeks Court Approval for $400 Million Settlement With Sandoz Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Brown Co-Leads Coalition of States in Pushing Back on Federal Rule That Could Undermine Medicaid, Insurance Regulation, and Health Coverage Published: 9/21/2026

CMS Announces Participants in Landmark Medicaid Drug Payment Model to Bring Down Drug Costs for Most Vulnerable Americans

Attorney General Aaron M. Frey Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Clark Seeks Court Approval for $358,000 Settlement with Sandoz Over Conspiracy to Inflate Prices and Limit Competition

Colorado slated to receive $2.1M from nationwide settlement with Sandoz over illegal generic drug price hikes and collusion

Attorney General Clark Joins Coalition of States in Pushing Back on Federal Rule That Could Undermine Medicaid, Insurance Regulation, and Health Coverage

MLN Connects Newsletter for September 24, 2026

Attorney General Brown Seeks Court Approval for Multistate Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition Published: 10/9/2026

Coalition Seeks Court Approval for Settlement With Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Generic Drug Prices

ALIGNMENT HEALTHCARE, INC. v. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Attorney General Alan Wilson urges consumers to claim compensation for inflated generic drug pricesRead More

Washington settles generic drug cases with Ascend Laboratories, Citron Pharma, and Mayne Pharma

Acting Alaska Attorney General Cori Mills Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Press Release OCT 8, 2026 AG Sunday’s Antitrust Section Seeks Court Approval for Settlements with 3 Generic Drug Makers Regarding Price Inflation HARRISBURG, Attorney General Dave Sunday joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma, and Mayne Pharma… Read more

Washington, multistate coalition seek approval for $400 million settlement in drug price-fixing case

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Tong Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Brown Urges Consumers to Claim Compensation for Inflated Generic Drug Prices Published: 9/23/2026

AG Davenport Challenges Trump Administration’s Public Charge Rule

Private Health Insurance: Market Concentration in 2024 Was Generally Higher Than in 2011

Attorney General Knudsen urges Montanans to claim compensation for inflated generic drug prices

Attorney General Mike Hilgers Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

AG Campbell Seeks Court Approval For Settlements With Generic Drug Manufacturers Over Conspiracy To Inflate Prices And Limit Competition

Attorney General Clark Encourages Eligible Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Aaron M. Frey Urges Consumer to Claim Compensation for Inflated Generic Drug Prices

Following Settlements With Generic Drug Manufacturers, AG's Office Urges Consumers To Claim Compensation For Inflated Generic Drug Prices

WA consumers urged to claim compensation for inflated generic drug prices

Health Insurance Exchanges: Coverage of Non-Excepted Abortion Services by Qualified Health Plans in 2026

Generic Drug Settlement Distribution

Attorney General Tong Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Rayfield Secures Patient Relief Over Inflated Drug Prices

DC PR 26-0793: Extension of Substance Use and Targeted Outreach Grants Emergency Declaration Resolution of 2026

R055-25RA

Attorney General Bonta Urges Consumers to Claim Compensation for Inflated Generic Drug Prices